Predictors of Response to Autologous Dendritic Cell Therapy in Glioblastoma Multiforme

Abstract

For patients receiving DC vaccine adjuvant therapy, better outcomes are predicted in patients with younger age, with TILs or PBMCs with lower PD-1⁺/CD8⁺ ratio, with gross tumor resection, and receiving CCRT.